Abstract. Brain Brain metastases from esophageal or gastric cancer account for approximately 2.1-3.3% of all brain tumors registered in Japan (1). Their prognosis is poor because there are no established therapeutic strategies (2). Here, we report a patient who survived for 5 years after treatment of a solitary cerebellar metastasis from cancer of the esophagogastric junction (EGJ) and review published case reports.
Case ReportThe patient, a 74-year-old woman who was 159.5 cm tall and weighed 45.5 kg, was diagnosed with advanced EGJ cancer and underwent total gastrectomy with splenectomy and D2 lymph node dissection. After an uncomplicated postoperative period, the patient was discharged from hospital on postoperative day 12. The primary EGJ cancer was diagnosed as Siewert type II, type 3 by pathological examination of the excised surgical specimen. Findings included type 3, tumor size 70 × 50 mm, moderately differentiated tubular adenocarcinoma, ss, ly1, v2, two lymph node metastases, and stage IIB according to the Japanese Classification of Gastric Carcinoma (3) (Figures 1 and 2). Six weeks postoperatively, the patient commenced adjuvant chemotherapy with 120 mg/kg of S-1. However, she developed grade 2 anorexia and systemic malaise according to Common Terminology Criteria for Adverse Events (CTCAE) version 4.0 (4), and therefore discontinued this treatment after 2 weeks, refused alternative chemotherapy and was only followed-up.
1209